Lowe's Companies
LOW
181.54
-2.13
-1.16%
Lowe's Companies
US · LOW
#189 by market cap
Listed 1970
181.54
-2.13
-1.16%
Live - 5344 symbols - heartbeat 27s ago
· 2026-10-08 08:30
Pre-market
180.70
-0.46%
After-hours
181.59
+0.03%
Overnight
181.25
-0.16%
- Market cap
- 101.85B
- P/E (TTM)i
- 15.35
- P/Bi
- -13.70
- EPSi
- 11.85
- Div yieldi
- 2.67%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on LOW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.92, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +3.12% YoY
Margins
- Gross margin
- 33.48%
- Operating margin
- 11.77%
- Net margin
- 7.69%
Key ratios & quality
- Enterprise valuei
- 141.51B
- PEG ratioi
- 13.81
- Altman Z-Scorei
- 2.92
PEG uses trailing P/E against the 3-year net income growth rate (1.11%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 71.31B | 72.15B | 89.60B | 96.25B | 97.06B | 86.38B | 83.67B | 86.29B |
| Gross profit | 22.91B | 22.94B | 29.57B | 32.06B | 32.26B | 28.84B | 27.88B | 28.89B |
| Selling & admin expenses | 17.41B | 15.37B | 18.53B | 18.30B | 20.33B | 15.57B | 15.68B | 16.79B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 4.02B | 6.31B | 9.65B | 12.09B | 10.16B | 11.56B | 10.47B | 10.15B |
| Pretax profit | 3.39B | 5.62B | 7.74B | 11.21B | 9.04B | 10.18B | 9.15B | 8.75B |
| Tax | 1.08B | 1.34B | 1.90B | 2.77B | 2.60B | 2.45B | 2.20B | 2.09B |
| Net profit | 2.31B | 4.28B | 5.84B | 8.44B | 6.44B | 7.73B | 6.96B | 6.65B |
| Basic EPS | 3 | 5 | 8 | 12 | 10 | 13 | 12 | 12 |
| Diluted EPS | 2.84 | 5.49 | 7.75 | 12.04 | 10.17 | 13.20 | 12.23 | 11.85 |
| Line item | 2025-05 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 20.93B | 23.96B | 20.81B | 20.59B | 23.08B | 25.96B |
| Gross profit | 6.99B | 8.10B | 7.12B | 6.68B | 7.54B | 8.58B |
| Selling & admin expenses | 4.05B | 4.18B | 4.16B | 4.41B | 4.42B | 4.46B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.49B | 3.47B | 2.48B | 1.71B | 2.55B | 3.55B |
| Pretax profit | 2.16B | 3.16B | 2.13B | 1.30B | 2.16B | 3.18B |
| Tax | 516.00M | 758.00M | 513.00M | 304.00M | 527.00M | 776.00M |
| Net profit | 1.64B | 2.40B | 1.62B | 1.00B | 1.63B | 2.40B |
| Basic EPS | 3 | 4 | 3 | 2 | 3 | 4 |
| Diluted EPS | 2.92 | 4.27 | 2.88 | 1.78 | 2.90 | 4.27 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 14.23B | 15.32B | 22.33B | 20.06B | 21.44B | 19.07B | 20.36B | 20.96B |
| Cash & ST investments | 511.00M | 716.00M | 4.69B | 1.13B | 1.35B | 921.00M | 1.76B | 982.00M |
| Inventory | 12.56B | 13.18B | 16.19B | 17.61B | 18.53B | 16.89B | 17.41B | 17.30B |
| Total assets | 34.51B | 39.47B | 46.74B | 44.64B | 43.71B | 41.80B | 43.10B | 54.14B |
| Total current liabilities | 14.50B | 15.18B | 18.73B | 19.67B | 19.51B | 15.57B | 18.76B | 19.46B |
| Short-term debt | 1.83B | 3.04B | 1.65B | 1.50B | 1.61B | 1.02B | 3.15B | 3.14B |
| Long-term debt | 14.39B | 16.77B | 20.67B | 23.86B | 32.88B | 35.38B | 32.90B | 37.49B |
| Total liabilities | 30,864,000,000.00 | 37,499,000,000.00 | 45,298,000,000.00 | 49,456,000,000.00 | 57,962,000,000.00 | 56,845,000,000.00 | 57,333,000,000.00 | 64,061,000,000.00 |
| Total equity | 3.64B | 1.97B | 1.44B | -4.82B | -14.25B | -15.05B | -14.23B | -9.92B |
| Retained earnings | 3.45B | 1.73B | 1.12B | -5.12B | -14.86B | -15.64B | -14.80B | -10.84B |
| Line item | 2025-05 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 22.68B | 22.64B | 20.22B | 20.96B | 22.16B | 23.34B |
| Cash & ST investments | 3.05B | 4.86B | 621.00M | 982.00M | 786.00M | 3.17B |
| Inventory | 18.34B | 16.34B | 17.18B | 17.30B | 18.45B | 17.74B |
| Total assets | 45.37B | 46.61B | 53.45B | 54.14B | 54.94B | 55.88B |
| Total current liabilities | 22.39B | 21.62B | 19.45B | 19.46B | 20.27B | 21.13B |
| Short-term debt | 4.75B | 4.71B | 3.13B | 3.14B | 1.85B | 3.09B |
| Long-term debt | 30.54B | 30.55B | 37.50B | 37.49B | 36.75B | 35.20B |
| Total liabilities | 58,626,000,000.00 | 58,014,000,000.00 | 63,835,000,000.00 | 64,061,000,000.00 | 64,211,000,000.00 | 63,318,000,000.00 |
| Total equity | -13.25B | -11.40B | -10.38B | -9.92B | -9.27B | -7.44B |
| Retained earnings | -13.83B | -12.11B | -11.17B | -10.84B | -9.88B | -8.19B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 6.19B | 4.30B | 11.05B | 10.11B | 8.59B | 8.14B | 9.63B | 9.86B |
| Depreciation & amortization | 1.61B | 1.41B | 1.59B | 1.88B | 1.98B | 1.92B | 1.97B | 2.19B |
| Free cash flow | 5.02B | 2.81B | 9.26B | 8.26B | 6.76B | 6.18B | 7.70B | 7.65B |
| Dividends paid | -1.46B | -1.62B | -1.70B | -1.98B | -2.37B | -2.53B | -2.57B | -2.64B |
| Stock buybacks / issuance | -3.04B | -4.31B | -4.97B | -13.01B | -14.12B | -6.14B | -4.05B | -211.00M |
| Ending cash balance | 511.00M | 716.00M | 4.69B | 1.13B | 1.35B | 921.00M | 1.76B | 982.00M |
| Line item | 2025-05 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 3.38B | 4.23B | 687.00M | 1.57B | 3.35B | 3.66B |
| Depreciation & amortization | 507.00M | 515.00M | 535.00M | 637.00M | 644.00M | 648.00M |
| Free cash flow | 2.86B | 3.74B | 90.00M | 964.00M | 2.83B | 3.12B |
| Dividends paid | -645.00M | -645.00M | -673.00M | -673.00M | -674.00M | -672.00M |
| Stock buybacks / issuance | -112.00M | -1.00M | -98.00M | 0 | -363.00M | -3.00M |
| Ending cash balance | 3.05B | 4.86B | 621.00M | 982.00M | 786.00M | 3.17B |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 48.48 | 151.99 | 340.92 | -- | -- | -- | -- | -- |
| ROA %i | 6.61 | 11.54 | 13.48 | 18.41 | 14.52 | 18.03 | 16.35 | 13.65 |
| ROIC %i | 12.79 | 21.03 | 24.17 | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | 40.23 | 65.71 | 128.14 | -- | -- | -- | -- | -- |
| EBIT margin %i | 5.67 | 8.79 | 9.61 | 12.58 | 10.51 | 13.50 | 12.70 | 11.91 |
| FCF / sales %i | 7.04 | 3.90 | 10.33 | 8.58 | 6.96 | 7.15 | 9.20 | 8.87 |
| Current ratioi | 0.98 | 1.01 | 1.19 | 1.02 | 1.10 | 1.23 | 1.09 | 1.08 |
| Quick ratioi | 0.04 | 0.05 | 0.25 | 0.06 | 0.07 | 0.06 | 0.10 | 0.11 |
| Debt / assetsi | 47.01 | 60.17 | 56.08 | 65.82 | 86.93 | 96.05 | 92.06 | 82.52 |
| LT debt / equityi | 394.92 | 1,050.25 | 1,708.98 | -- | -- | -- | -- | -- |
| Interest coveragei | 6.21 | 8.83 | 9.88 | 13.49 | 8.79 | 7.86 | 7.22 | 6.73 |
| Revenue CAGR (3Y) %i | 6.48 | 3.53 | 9.30 | 10.51 | 10.39 | -1.21 | -4.56 | -3.85 |
| Net income CAGR (3Y) %i | -3.13 | 11.47 | 19.18 | 53.94 | 14.56 | 9.81 | -6.25 | 1.11 |
| FCF CAGR (3Y) %i | 11.85 | -14.19 | 32.92 | 18.06 | 33.96 | -12.62 | -2.32 | 4.21 |
| Line item | 2025-05 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 15.05 | 14.94 | 13.77 | 13.65 | 13.20 | 12.93 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.58 | 12.54 | 12.36 | 11.91 | 11.67 | 11.47 |
| FCF / sales %i | 8.02 | 9.19 | 8.37 | 8.87 | 8.62 | 7.74 |
| Current ratioi | 1.01 | 1.05 | 1.04 | 1.08 | 1.09 | 1.10 |
| Quick ratioi | 0.14 | 0.22 | 0.09 | 0.11 | 0.10 | 0.21 |
| Debt / assetsi | 85.86 | 83.79 | 83.62 | 82.52 | 77.43 | 75.20 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 7.17 | 7.25 | 7.07 | 6.73 | 6.56 | 6.44 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Retail Home Improvement is the largest reported line at 92.52% of revenue, across 2 reported segments.
- The next-largest line, Other, is a distant second at 7.48% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Retail Home Improvement92.52%
Other7.48%
Quote time 2026-10-08 08:30:07 · For reference only, not investment advice and not tailored to your situation.